e-learning
resources
Milan 2017
Sunday, 10.09.2017
Towards better treatments for lung disease: experimental pharmacology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1
T. Hwang (Taoyuan, Taiwan)
Source:
International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Session:
Towards better treatments for lung disease: experimental pharmacology
Session type:
Thematic Poster
Number:
1044
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Hwang (Taoyuan, Taiwan). Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1. 1044
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Incorrect inhaler technique is common in patients with COPD – Data from the TIE study
A prospective study of the effect of carbocysteine lysine salt on COPD exacerbations with or without inhaled steroids
The novel elastase inhibitor BAY 85-8501 provides a new approach in the treatment of pulmonary diseases
Related content which might interest you:
Inhibition of neutrophil apoptosis by sphingosin-1-phopsphate through the activation of neutral sphingomyelinase in acute lung injury
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Effect of curcumin on LPS-induced neutrophil activation and acute lung injury
Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation
Year: 2012
Ethyl pyruvate prevents lung injury through inhibition of the NF-kappa B pathway, but does not prevent bleomycin-induced lung injury
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment
Source: Eur Respir J 2012; 40: 416-423
Year: 2012
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Kallistatin protects against LPS-induced mouse lung injury
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Tetracycline alleviates acute lung injury by inhibition of NLRP3 inflammasome
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
RAGE deficiency improves alveolar fluid clearance in LPS-induced acute lung injury by preventing downregulation of Na-K-ATPase and ENaC
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Inhibition of neutrophil elastase contributes to attenuationof lipopolysaccharide-induced acute lung injuryduring neutropenia recovery in mice
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
CD101 eosinophil serves as an early response to suppress endotoxin-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Evidence that cathepsin G counteracts the profibrotic effects of neutrophil elastase following lung injury
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001
Phosphoinositide 3-kinase γ required for lipopolysaccharide-induced transepithelial neutrophil trafficking in the lung
Source: Eur Respir J 2010; 35: 1137-1147
Year: 2010
Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
Sirtuins inhibition modulates endotoxin-induced lung inflammation
Source: Annual Congress 2010 - Models of airways disease
Year: 2010
A role for PAR1 in lipopolysaccharide induced acute lung injury
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Surfactant protein A modulate bleomycin-induced lung injury in toll-like receptor 2 dependent pathway
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats
Source: International Congress 2015 – Neonatal and paediatric intensive care
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept